KTOS Insider Notice — Phillip Carrai Sells 18,000 Shares; Proposed 6,000-Share Sale
Rhea-AI Filing Summary
Insider sale notice for KTOS. This Form 144 shows proposed and recent sales of common stock by Phillip Carrai. The filing reports a proposed sale of 6,000 shares with an aggregate market value of $412,912.20 to be executed on 09/15/2025 on NASDAQ. It also discloses three recent sales during the past three months: 6,000 shares on 08/15/2025 for $406,690.20, 6,000 shares on 07/15/2025 for $308,503.20, and 6,000 shares on 06/16/2025 for $252,967.20, totaling 18,000 shares and $968,160.60 in gross proceeds. The shares originated as restricted stock granted by the issuer on 01/03/2022 and 01/04/2024.
Positive
- Timely regulatory disclosure of insider sales under Rule 144
- Detailed transaction data provided (dates, broker, gross proceeds, market)
Negative
- Insider liquidity evidenced by 18,000 shares sold in three months (may be perceived negatively by some investors)
- No contextual explanation in the filing for the purpose of the sales beyond standard representations
Insights
TL;DR: Multiple scheduled and recent insider sales totaling 18,000 shares; routine disclosure without additional context.
The filing documents compliant sales activity under Rule 144 by Phillip Carrai, including a proposed sale and three completed transactions in the prior three months. The disclosed origin of the shares is restricted stock issued by the company on specific dates in 2022 and 2024. The transactions are reported with execution dates, broker name and gross proceeds, enabling transparent tracking of insider liquidity. Absent additional company disclosure, these are administrative insider sales rather than event-driven changes to business fundamentals.
TL;DR: The Form 144 is a standard compliance filing; it signals insider liquidity but provides no new operational information.
The notice includes the broker (Morgan Stanley Smith Barney LLC Executive Financial Services), the marketplace (NASDAQ), and the relationship that the securities were acquired from the issuer as restricted stock. The filer’s representation about lack of undisclosed material information is present on the form. From a governance perspective, timely disclosure of these sales aligns with regulatory expectations; the form does not indicate any change in executive role or governance actions.
FAQ
Who filed this Form 144 for KTOS?
How many shares were sold by the insider in the past three months?
What were the gross proceeds from the recent insider sales?
What is the proposed sale reported on this Form 144?
How were the shares acquired that are being sold?